Management of Endometrial Cancer: French Society of Onco-Gynecology's Evaluation through a Delphi Survey.
Fiche publication
Date publication
novembre 2022
Journal
Journal of clinical medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr AKLADIOS Chérif
Tous les auteurs :
Marti C, Deluche E, Jochum F, Bendifallah S, Azais H, Deidier J, Cockenpot V, Menoux I, Balaya V, Betrian S, Chargari C, Gouy S, Genestie C, Feki A, Uzan C, Guyon F, Devouassoux-Shisheboran M, Body N, Akladios C, Mathevet P, Guani B, On Behalf Of The Sfog And The Sfog Campus
Lien Pubmed
Résumé
Our aim was to assess the opinion of a panel of experts and obtain a consensus on the management of endometrial cancer in France and French Switzerland. A Delphi survey was carried out among a panel of French and French-speaking Swiss experts. The first questionnaire included 65 questions divided into eight categories: characterization of experts, histo-molecular characteristics and radiological data of endometrial cancer, and management of low-risk, intermediate-risk, intermediate-high-risk, high-risk, and metastatic cancers. The experts were asked to reply on a 9-point scale, both on the validity and the clarity of each question. After the answers were analyzed, a second questionnaire was sent to the same experts. The study took place between December 2021 and March 2022. Further, 58 (57.4%) of the 101 experts responded in the first round, and 39 recommendations were obtained (60%). Six questions were voted redundant and 20 discordant. These questions were reformulated, and, at the end of the second round, 17 recommendations were validated (85%). In total, the study presents an analysis of 56 questions and related responses. Expert advice helps to clarify non-consensual issues, standardize the management of endometrial cancer, and optimize clinical practices.
Mots clés
Delphi procedure, SFOG guidelines, endometrial cancer, endometrial cancer guidelines
Référence
J Clin Med. 2022 11 15;11(22):